HomeNDC LookupDrug shortages › Streptozocin Powder, For Solution

Streptozocin Powder, For Solution shortage

Streptozocin Powder, For Solution is currently listed in shortage by the FDA. The FDA lists 2 affected products. The reported reason: Other. This page was last refreshed from FDA data on Sep 15, 2026.

Current ⚠ Supply risk: High Oncology 2 products 2 manufacturers 1,526 days · 4.2 yr First posted Jul 12, 2022 Updated Sep 1, 2026
Here’s the bottom line

Streptozocin powder for solution is in shortage, and the 100 mg/1 mL concentration has no available source right now. The 1 g/10 mL strength still has a listed supply from one manufacturer not reporting a shortage.

Don’t stop or change your therapy on your own — ask your pharmacist about other manufacturers (see options) and your prescriber about a long-term plan.

Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →
2
Affected NDCs
2
Reporting manufacturers
1/2
Reporting mfrs supplying
1/2
Affected strengths supplied
50%
NDCs unavailable
1,526
Days in shortage
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Sep 15, 2026 · yesterday

What’s in shortage — at a glance

These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Streptozocin Powder, For Solution. Other makers that haven’t reported a problem are shown in the green card below.

Availability of affected NDCs
From the FDA shortage report
2 NDCs
Available 1 Unavailable 1
Affected strengths still supplied
Among manufacturers reporting this shortage
1/2 strengths
Sourceable 1 No supply 1
FDA-reporting manufacturers with supply
Among manufacturers reporting this shortage
1/2 makers
With supply 1 No supply 1
✓ Other manufacturers not reporting a shortage
Still-marketed Streptozocin Powder, For Solution from companies that have not filed an FDA shortage — these are not counted in the figures above. Stock can still vary by pharmacy.
ESTEVE PHARMACEUTICALS, S.A.
See all other options & details →
Shortage timeline
  1. Sep 1, 2026
    Currently in shortage
    2 of 2 products affected.
  2. May 6, 2026
    FDA refreshed this shortage record
    1 product updated.
  3. Jul 12, 2022
    First reported to the FDA
    2 products first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

What exactly is on backorder — by manufacturer

Manufacturer: ESTEVE PHARMACEUTICALS, S.A. 📞 [email protected] 1 NDC click to expand
Status NDC / product Strength Availability Related information Reason
Current Zanosar, Powder, For Solution, 1 g/10 mL (NDC 68118-100-01) NDC 68118-0100-01 Available
Manufacturer: Teva Pharmaceuticals USA, Inc. 📞 800-545-8800 1 NDC click to expand
Status NDC / product Strength Availability Related information Reason
Current Zanosar, Powder, For Solution, 100 mg/1 mL (NDC 0703-4636-01) NDC 00703-4636-01 Unavailable Estimated recovery: TBD Other

These rows are manufacturer reports to the FDA for Streptozocin Powder, For Solution — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Streptozocin Powder, For Solution? options further down this page.

Why is Streptozocin Powder, For Solution in shortage?

Right now, the specific version of Zanosar (streptozocin) that Teva Pharmaceuticals makes — the 100 mg/1 mL powder for solution — is unavailable. Teva reported the reason as "other," which unfortunately means they didn't share a specific public explanation for why this is happening. There's also no firm timeline for when it might be back; their estimated recovery date is listed as "TBD," meaning to be determined.

It's worth knowing that this shortage report covers only Teva's 100 mg/1 mL package. The 1 g/10 mL version of Zanosar, made by ESTEVE Pharmaceuticals, is currently listed as available.

FDA reason code(s): Other

Based on the manufacturer-reported reason(s) and notes on file with the FDA for Streptozocin Powder, For Solution, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.

What should I do if I take Streptozocin Powder, For Solution?

Streptozocin (also sold as Zanosar), a powder for solution, is currently on the FDA drug-shortage list. I want to walk you through what this means so you can find the strength you take.

The two strengths are affected differently. The 1 g/10 mL strength still has an available source from a manufacturer, so supply is reported for it. The 100 mg/1 mL strength currently has no available source — the maker that reported it, Teva, lists it as unavailable, with an estimated recovery date still to be determined. The reason on file is listed only as "Other." This shortage has lasted more than a year, and one of the two manufacturers on this record is still reporting supply.

Here is what I suggest, in order:

  • Do not stop, skip, or change your dose on your own.
  • If you take the 1 g/10 mL strength, ask your pharmacy to order it — pharmacies can check wholesalers and other manufacturers.
  • If your strength is the 100 mg/1 mL, ask your prescriber or pharmacist about options, such as using a different available strength to make up the dose or a clinician-chosen alternative.
  • Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle these calls.

This is national, manufacturer-reported data and may not match your local pharmacy's actual stock.

See “Where else can I get Streptozocin Powder, For Solution?” below ↓ The same medicine from manufacturers not reporting a shortage, alternative dosage forms, and therapeutic equivalents with pricing.
If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Keep reading
Our full Cetirizine guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Cetirizine guide →

Where else can I get Streptozocin Powder, For Solution?

FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Streptozocin Powder, For Solution is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same medicine, other manufacturers (not reported short)

Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:

ProductStrengthForm / routeManufacturerNDC
Quzyttir CETIRIZINE HYDROCHLORIDE 10 mg/mL Injection · Intravenous ESTEVE PHARMACEUTICALS, S.A. 68118-0100-10
Therapeutic equivalents & pricing 4 productsclick to expand

Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Quzyttir 10 mg/mLNDC 68118-0100-01 ESTEVE 1 vial Discontinued
Quzyttir 10 mg/mLNDC 70720-0100-10 TerSera 1 vial FDA listed
Quzyttir 10 mg/mLNDC 68118-0200-10 ESTEVE 1 vial FDA listed
Zanosar 100 mg/mLNDC 00703-4636-01 Teva 10 ml Discontinued

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Other drugs in the same treatment class

These are different medicines — not other versions of Streptozocin Powder, For Solution — that fall in the same broad treatment class (antibiotic antineoplastics) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Identity & classification

GCN Seq No 008825
GCN 38630
HICL code 003920
Ingredient (HICL) Streptozocin
HIC1 code V
Therapeutic class — broad (HIC1) Neoplasms
HIC2 code V1
Therapeutic class — intermediate (HIC2) Antineoplastic Drugs
HIC3 code V1D
Therapeutic class — specific (HIC3) Antibiotic Antineoplastics
AHFS code 10:00.00.00
AHFS class Antineoplastic Agents
FDB label name ZANOSAR 1 GM VIAL
FDB brand name Zanosar
Legend status F — Federal legend — prescription drug or device
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other oncology shortages

Streptozocin Powder, For Solution shortage FAQs

Is Streptozocin Powder, For Solution in shortage?
Yes — the FDA currently lists Streptozocin Powder, For Solution in shortage (status: “Current”, first reported Jul 12, 2022). 2 of 2 products are affected. This is national, manufacturer-reported data, so your pharmacy may still have stock.
Why is Streptozocin Powder, For Solution in shortage?
The manufacturer-reported reason on file with the FDA: Other.
Which products are affected?
Zanosar, Powder, For Solution, 1 g/10 mL (NDC 68118-100-01) (NDC 68118-0100-01); Zanosar, Powder, For Solution, 100 mg/1 mL (NDC 0703-4636-01) (NDC 00703-4636-01). The full per-NDC list (availability, manufacturer and status) is in the table above — each NDC links to its own page.
When will Streptozocin Powder, For Solution be available again?
The FDA does not publish a guaranteed restock date, and no estimated-recovery note is on file. Availability can change daily — confirm with your pharmacy.
Can I still get Streptozocin somewhere?
Other manufacturers (ESTEVE PHARMACEUTICALS, S.A.) still market it and have not reported a shortage. See “Where else can I get Streptozocin Powder, For Solution?” above — stock still varies by pharmacy.
What should I do if I take Streptozocin Powder, For Solution?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another manufacturer or a different strength/package size, and ask your prescriber about a long-term plan before your supply runs out.

Still have a question about the Streptozocin Powder, For Solution shortage?

Ask a pharmacist about this shortage →
How to read the Supply-Risk rating
Low (1–2)Multiple manufacturers still supplying and most strengths or pack sizes sourceable.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes unsourceable, or a long-running outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages